Coldstream Capital Management Inc. trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 9.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,825 shares of the biotechnology company's stock after selling 699 shares during the quarter. Coldstream Capital Management Inc.'s holdings in Axon Enterprise were worth $4,056,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise in the 4th quarter worth $40,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $45,000. Stonebridge Financial Group LLC bought a new position in shares of Axon Enterprise during the fourth quarter worth about $53,000. GPS Wealth Strategies Group LLC raised its position in Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock valued at $56,000 after buying an additional 40 shares during the last quarter. Finally, Versant Capital Management Inc lifted its stake in Axon Enterprise by 4,750.0% in the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock valued at $58,000 after acquiring an additional 95 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.
Analysts Set New Price Targets
AXON has been the subject of several research reports. Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. The Goldman Sachs Group raised their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Finally, Needham & Company LLC restated a "buy" rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus price target of $626.45.
View Our Latest Research Report on AXON
Insider Activity
In other news, Director Jeri Williams sold 307 shares of the company's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company's stock, valued at $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This represents a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company's stock.
Axon Enterprise Price Performance
Shares of NASDAQ AXON traded up $7.80 during midday trading on Thursday, reaching $621.10. The company's stock had a trading volume of 448,714 shares, compared to its average volume of 761,440. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The business's 50 day moving average price is $549.12 and its two-hundred day moving average price is $574.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market cap of $48.35 billion, a P/E ratio of 160.49, a P/E/G ratio of 5.17 and a beta of 1.13.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.